Sridhar S - Search Results

1

Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.

Zimmermann C, Pope A, Hannon B, Krzyzanowska MK, Rodin G, Li M, Howell D, Knox JJ, Leighl NB, Sridhar S, Oza AM, Prince R, Lheureux S, Hansen AR, Rydall A, Chow B, Herx L, Booth CM, Dudgeon D, Dhani N, Liu G, Bedard PL, Mathews J, Swami N, Le LW. Zimmermann C, et al. Among authors: sridhar s. J Natl Compr Canc Netw. 2021 Sep 7;20(4):361-370.e3. doi: 10.6004/jnccn.2020.7803. J Natl Compr Canc Netw. 2021. PMID: 34492632 Clinical Trial.

2

Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.

Dhani NC, Emmenegger U, Adams L, Jongstra J, Tannock IF, Sridhar SS, Knox JJ, Day JR, Groskopf J, Joshua AM. Dhani NC, et al. Among authors: sridhar ss. BJU Int. 2012 Sep;110(6):840-5. doi: 10.1111/j.1464-410X.2011.10922.x. Epub 2012 Feb 7. BJU Int. 2012. PMID: 22313860 Clinical Trial.

3

Use of a clinical assistant to screen patients with genitourinary cancer to encourage entry into clinical trials and use of supportive medication: a pilot project at a Canadian cancer center.

Lun G, Atenafu EG, Knox JJ, Sridhar SS, Tannock IF, Joshua AM. Lun G, et al. Among authors: sridhar ss. Clin Genitourin Cancer. 2013 Sep;11(3):342-345.e1. doi: 10.1016/j.clgc.2013.04.008. Epub 2013 May 9. Clin Genitourin Cancer. 2013. PMID: 23665134

4

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials.

Templeton AJ, Vera-Badillo FE, Wang L, Attalla M, De Gouveia P, Leibowitz-Amit R, Knox JJ, Moore M, Sridhar SS, Joshua AM, Pond GR, Amir E, Tannock IF. Templeton AJ, et al. Among authors: sridhar ss. Ann Oncol. 2013 Dec;24(12):2972-7. doi: 10.1093/annonc/mdt397. Epub 2013 Oct 14. Ann Oncol. 2013. PMID: 24126362 Free article.

5

A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer.

Sridhar SS, Joshua AM, Gregg R, Booth CM, Murray N, Golubovic J, Wang L, Harris P, Chi KN. Sridhar SS, et al. Clin Genitourin Cancer. 2015 Apr;13(2):124-9. doi: 10.1016/j.clgc.2014.06.001. Epub 2014 Jun 8. Clin Genitourin Cancer. 2015. PMID: 24993934 Free PMC article. Clinical Trial.

6

Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole.

Leibowitz-Amit R, Seah JA, Atenafu EG, Templeton AJ, Vera-Badillo FE, Alimohamed N, Knox JJ, Tannock IF, Sridhar SS, Joshua AM. Leibowitz-Amit R, et al. Among authors: sridhar ss. Eur J Cancer. 2014 Sep;50(14):2399-407. doi: 10.1016/j.ejca.2014.06.004. Epub 2014 Jul 16. Eur J Cancer. 2014. PMID: 25042152

7

Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone.

Leibowitz-Amit R, Alimohamed N, Vera-Badillo FE, Seah JA, Templeton AJ, Knox JJ, Tannock IF, Sridhar SS, Joshua AM. Leibowitz-Amit R, et al. Among authors: sridhar ss. Prostate. 2014 Oct;74(14):1462-4. doi: 10.1002/pros.22861. Epub 2014 Aug 11. Prostate. 2014. PMID: 25111736

8

Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer.

Leibowitz-Amit R, Templeton AJ, Alibhai SM, Knox JJ, Sridhar SS, Tannock IF, Joshua AM. Leibowitz-Amit R, et al. Among authors: sridhar ss. J Geriatr Oncol. 2015 Jan;6(1):23-8. doi: 10.1016/j.jgo.2014.09.183. Epub 2014 Oct 7. J Geriatr Oncol. 2015. PMID: 25301537

9

Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.

Seah JA, Leibowitz-Amit R, Atenafu EG, Alimohamed N, Knox JJ, Joshua AM, Sridhar SS. Seah JA, et al. Among authors: sridhar ss. Clin Genitourin Cancer. 2015 Aug;13(4):e229-e233. doi: 10.1016/j.clgc.2015.02.001. Epub 2015 Feb 7. Clin Genitourin Cancer. 2015. PMID: 25777682

10

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.

Emmenegger U, Booth CM, Berry S, Sridhar SS, Winquist E, Bandali N, Chow A, Lee C, Xu P, Man S, Kerbel RS, Ko YJ. Emmenegger U, et al. Among authors: sridhar ss. Oncologist. 2015 Dec;20(12):1351-2. doi: 10.1634/theoncologist.2015-0220. Epub 2015 Nov 5. Oncologist. 2015. PMID: 26542984 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,242 results

Search Page

Filters